Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR
- PMID: 23325741
- PMCID: PMC6807317
- DOI: 10.1002/jcla.21558
Rapid genotypic detection of rpoB and katG gene mutations in Mycobacterium tuberculosis clinical isolates from Northern India as determined by MAS-PCR
Abstract
Background: There is a growing need to develop rapid laboratory research methods to counter the menace of drug resistant tuberculosis (MDR-TB) cases worldwide especially in developing countries. The present study was undertaken to investigate the type and frequency of rpoB and katG mutations in rifampicin (RIF) and isoniazid (INH) resistant strains respectively of Mycobacterium tuberculosis (MTB) circulating in Northern India and to explore the utility of multiplex-allele-specific (MAS)-PCR assay for detection of drug-resistant MTB isolates in low resource set up.
Methods: Phenotypic and genotypic drug susceptibility testing (DST) was performed on 354 MTB isolates.
Results: Mutation in rpoB gene was found most frequently at codons 531, 526 and 516 (59.83%, 45.29% and 22.22%, respectively). Further, combinations of 2-3 point mutations were also observed in 19.66% of RIF-resistant MTB strains. The frequency of mutations in katG gene was found at codon 315 among 82.95% of the INH-resistant MTB isolates. MAS-PCR detected rpoB and katG mutations in phenotypically resistant isolates with sensitivities of 93% and 83% respectively.
Conclusion: MAS-PCR assays can be used for rapid detection of drug-resistant TB strains in routine diagnostic practice, enabling early administration of appropriate treatment regimens to the affected patients.
© 2012 Wiley Periodicals, Inc.
Figures

Similar articles
-
Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.BMC Infect Dis. 2013 Oct 15;13:478. doi: 10.1186/1471-2334-13-478. BMC Infect Dis. 2013. PMID: 24128118 Free PMC article.
-
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z. BMC Infect Dis. 2019. PMID: 30606116 Free PMC article.
-
Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.Pan Afr Med J. 2017 Jun 28;27:145. doi: 10.11604/pamj.2017.27.145.10883. eCollection 2017. Pan Afr Med J. 2017. PMID: 28904673 Free PMC article.
-
Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis.J Glob Antimicrob Resist. 2021 Sep;26:207-218. doi: 10.1016/j.jgar.2021.06.009. Epub 2021 Jun 30. J Glob Antimicrob Resist. 2021. PMID: 34214698
-
Multidrug-resistant tuberculosis.Clin Chim Acta. 2024 Jun 1;559:119701. doi: 10.1016/j.cca.2024.119701. Epub 2024 May 1. Clin Chim Acta. 2024. PMID: 38697459 Review.
Cited by
-
Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran.Iran J Pathol. 2018 Fall;13(4):429-437. Epub 2018 Sep 25. Iran J Pathol. 2018. PMID: 30774682 Free PMC article.
-
Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia.SAGE Open Med. 2022 May 20;10:20503121221098241. doi: 10.1177/20503121221098241. eCollection 2022. SAGE Open Med. 2022. PMID: 35646363 Free PMC article.
-
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.Infect Drug Resist. 2022 Apr 8;15:1717-1732. doi: 10.2147/IDR.S345855. eCollection 2022. Infect Drug Resist. 2022. PMID: 35422638 Free PMC article.
-
Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand.World J Microbiol Biotechnol. 2021 Oct 13;37(11):194. doi: 10.1007/s11274-021-03163-7. World J Microbiol Biotechnol. 2021. PMID: 34642828
-
Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears.PLoS One. 2017 Dec 7;12(12):e0189149. doi: 10.1371/journal.pone.0189149. eCollection 2017. PLoS One. 2017. PMID: 29216262 Free PMC article.
References
-
- RNTCP, Annual Status Report 2009. Available from: http://www.tbcindia.org (http://planningcommission.nic.in/reports/genrep/health/RNTCP_2011.pdf) Accessed on 2012 July 20.
-
- Centers for Disease Control and Prevention (CDC) . Trends in tuberculosis – United States, 2008. Morb Mortal Wkly Rep 2009;58:249–253. - PubMed
-
- WHO . Global Tuberculosis Control: Epidemiology, Strategy, Financing WHO Report 2009. Geneva: World Health Organization; 2009. (WHO /HTM/ TB/2009.411).
-
- Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998;79:3–29. - PubMed
-
- Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JD. Characterization of the catalase‐peroxidase gene (katG) and inhA locus in isoniazid‐resistant and ‐susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance. J Infect Dis 1996:173:196–202. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases